These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7916060)

  • 1. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.
    Lazaro I; Naniche D; Signoret N; Bernard AM; Marguet D; Klatzmann D; Dragic T; Alizon M; Sattentau Q
    J Virol; 1994 Oct; 68(10):6535-46. PubMed ID: 7916060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD26 antigen and HIV fusion?
    Alizon M; Dragic T
    Science; 1994 May; 264(5162):1161-2; author reply 1162-5. PubMed ID: 7909962
    [No Abstract]   [Full Text] [Related]  

  • 3. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
    Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
    J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.
    Morimoto C; Lord CI; Zhang C; Duke-Cohan JS; Letvin NL; Schlossman SF
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9960-4. PubMed ID: 7937926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells.
    Callebaut C; Krust B; Jacotot E; Hovanessian AG
    Science; 1993 Dec; 262(5142):2045-50. PubMed ID: 7903479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD26 antigen and HIV fusion?
    Camerini D; Planelles V; Chen IS
    Science; 1994 May; 264(5162):1160-1; author reply 1162-5. PubMed ID: 7909961
    [No Abstract]   [Full Text] [Related]  

  • 7. CD26 antigen and HIV fusion?
    Broder CC; Nussbaum O; Gutheil WG; Bachovchin WW; Berger EA
    Science; 1994 May; 264(5162):1156-9; author reply 1162-5. PubMed ID: 7909959
    [No Abstract]   [Full Text] [Related]  

  • 8. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
    J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.
    Spina CA; Guatelli JC; Richman DD
    J Virol; 1995 May; 69(5):2977-88. PubMed ID: 7707524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD26 antigen and HIV fusion?
    Patience C; McKnight A; Clapham PR; Boyd MT; Weiss RA; Schulz TF
    Science; 1994 May; 264(5162):1159-60; author reply 1162-5. PubMed ID: 7909960
    [No Abstract]   [Full Text] [Related]  

  • 11. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.
    Chen BK; Gandhi RT; Baltimore D
    J Virol; 1996 Sep; 70(9):6044-53. PubMed ID: 8709227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCR analysis of HIV1 infection of macrophages: virus entry is CD4-dependent.
    Collin M; Herbein G; Montaner L; Gordon S
    Res Virol; 1993; 144(1):13-9. PubMed ID: 8446772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line.
    Harrington RD; Geballe AP
    J Virol; 1993 Oct; 67(10):5939-47. PubMed ID: 7690415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1.
    Zachar V; Spire B; Hirsch I; Chermann JC; Ebbesen P
    J Virol; 1991 Apr; 65(4):2102-7. PubMed ID: 1705998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus type 1 infection in a T-cell line (CEM) by new dipeptidyl-peptidase IV (CD26) inhibitors.
    Jiang JD; Wilk S; Li J; Zhang H; Bekesi JG
    Res Virol; 1997; 148(4):255-66. PubMed ID: 9272576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abortive infection in HeLaCD4 cells by a primary HIV type 1 isolate: implications for differential host cell tropism.
    Smyth RJ; Yi Y; Kim FM; Collman RG
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):759-69. PubMed ID: 9171220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
    Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of tryptase TL2 and CD26 antigen in brain-derived cells non-permissive to T-cell line-tropic human immunodeficiency virus type 1.
    Shimizu N; Kobayashi M; Liu HY; Kido H; Hoshino H
    FEBS Lett; 1995 Jan; 358(1):48-52. PubMed ID: 7821428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The level of CD26 determines the rate of HIV entry in a CD4+ T-cell line.
    Callebaut C; Jacotot E; Blanco J; Krust B; Hovanessian AG
    Adv Exp Med Biol; 1997; 421():179-84. PubMed ID: 9330695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay.
    Barbeau B; Fortin JF; Genois N; Tremblay MJ
    J Virol; 1998 Sep; 72(9):7125-36. PubMed ID: 9696806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.